Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Padmanee Sharma(The University of Texas MD Anderson Cancer Center), Klaus W. Wagner(The University of Texas MD Anderson Cancer Center), Jedd D. Wolchok(Memorial Sloan Kettering Cancer Center), James P. Allison(Howard Hughes Medical Institute)
Cited by 637
Abstract
Related Papers
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Daniel H. Kaplan, Vijay Shankaran, Anand S. Dighe et al.|Proceedings of the National Academy of Sciences|1998|1.4k